464 related articles for article (PubMed ID: 17261469)
1. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model.
Sharabi Y; Oron-Herman M; Kamari Y; Avni I; Peleg E; Shabtay Z; Grossman E; Shamiss A
Am J Hypertens; 2007 Feb; 20(2):206-10. PubMed ID: 17261469
[TBL] [Abstract][Full Text] [Related]
2. Hepatic effects of rosiglitazone in rats with the metabolic syndrome.
Ackerman Z; Oron-Herman M; Pappo O; Peleg E; Safadi R; Schmilovitz-Weiss H; Grozovski M
Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):663-8. PubMed ID: 20210788
[TBL] [Abstract][Full Text] [Related]
3. Metabolic stress with a high carbohydrate diet increases adiponectin levels.
Kamari Y; Grossman E; Oron-Herman M; Peleg E; Shabtay Z; Shamiss A; Sharabi Y
Horm Metab Res; 2007 May; 39(5):384-8. PubMed ID: 17533582
[TBL] [Abstract][Full Text] [Related]
4. Risk reduction therapy for syndrome X: comparison of several treatments.
Oron-Herman M; Sela BA; Rosenthal T
Am J Hypertens; 2005 Mar; 18(3):372-8. PubMed ID: 15797656
[TBL] [Abstract][Full Text] [Related]
5. Tetrahydrobiopterin prevents endothelial dysfunction and restores adiponectin levels in rats.
Wang X; Hattori Y; Satoh H; Iwata C; Banba N; Monden T; Uchida K; Kamikawa Y; Kasai K
Eur J Pharmacol; 2007 Jan; 555(1):48-53. PubMed ID: 17098227
[TBL] [Abstract][Full Text] [Related]
6. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
Fernandes-Santos C; Carneiro RE; de Souza Mendonca L; Aguila MB; Mandarim-de-Lacerda CA
Nutrition; 2009; 25(7-8):818-27. PubMed ID: 19268533
[TBL] [Abstract][Full Text] [Related]
7. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
[TBL] [Abstract][Full Text] [Related]
8. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
Shih CC; Lin CH; Lin WL; Wu JB
J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
[TBL] [Abstract][Full Text] [Related]
9. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model.
Wu LY; Juan CC; Hwang LS; Hsu YP; Ho PH; Ho LT
Eur J Nutr; 2004 Apr; 43(2):116-24. PubMed ID: 15083319
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome.
Aquilante CL; Kosmiski LA; Zineh I; Rome LC; Knutsen SD
Pharmacotherapy; 2010 Mar; 30(3):236-47. PubMed ID: 20180607
[TBL] [Abstract][Full Text] [Related]
11. Effect of telmisartan, angiotensin II receptor antagonist, on metabolic profile in fructose-induced hypertensive, hyperinsulinemic, hyperlipidemic rats.
Kamari Y; Harari A; Shaish A; Peleg E; Sharabi Y; Harats D; Grossman E
Hypertens Res; 2008 Jan; 31(1):135-40. PubMed ID: 18360028
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production.
Hoo RL; Chow WS; Yau MH; Xu A; Tso AW; Tse HF; Fong CH; Tam S; Chan L; Lam KS
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2777-82. PubMed ID: 17932317
[TBL] [Abstract][Full Text] [Related]
13. A fat-enriched, glucose-enriched diet markedly attenuates adiponectin mRNA levels in rat epididymal adipose tissue.
Naderali EK; Estadella D; Rocha M; Pickavance LC; Fatani S; Denis RG; Williams G
Clin Sci (Lond); 2003 Oct; 105(4):403-8. PubMed ID: 12780342
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome: comparison of the two commonly used animal models.
Oron-Herman M; Kamari Y; Grossman E; Yeger G; Peleg E; Shabtay Z; Shamiss A; Sharabi Y
Am J Hypertens; 2008 Sep; 21(9):1018-22. PubMed ID: 18566592
[TBL] [Abstract][Full Text] [Related]
15. Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment.
Liu Y; Chewchuk S; Lavigne C; Brûlé S; Pilon G; Houde V; Xu A; Marette A; Sweeney G
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E657-64. PubMed ID: 19531641
[TBL] [Abstract][Full Text] [Related]
16. Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndrome.
Samaha FF; Szapary PO; Iqbal N; Williams MM; Bloedon LT; Kochar A; Wolfe ML; Rader DJ
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):624-30. PubMed ID: 16357312
[TBL] [Abstract][Full Text] [Related]
17. Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome.
Esposito K; Ciotola M; Carleo D; Schisano B; Saccomanno F; Sasso FC; Cozzolino D; Assaloni R; Merante D; Ceriello A; Giugliano D
Diabetes Care; 2006 May; 29(5):1071-6. PubMed ID: 16644639
[TBL] [Abstract][Full Text] [Related]
18. The effects of physiological and pharmacological weight loss on adiponectin and leptin mRNA levels in the rat epididymal adipose tissue.
Naderali EK; Fatani S; Telles M; Hunter L
Eur J Pharmacol; 2008 Jan; 579(1-3):433-8. PubMed ID: 18155694
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone increases extravasation of macromolecules and endothelial nitric oxide synthase in skeletal muscles of the fructose-fed rat model.
St-Pierre P; Bouffard L; Maheux P
Biochem Pharmacol; 2004 May; 67(10):1997-2004. PubMed ID: 15130775
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
Miyazaki Y; DeFronzo RA
Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
